Greenrose Acquisition Corp. a special purpose acquisition company targeting companies in the cannabis industry, announced that it has increased its full year 2022 financial projections for revenue and adjusted EBITDA, as stated in the revised investor presentation filed with the SEC on July 28 th 2021. Greenrose’s expanded financial projections reflect Theraplant’s additional upside potential from ...